REG - Abbott Laboratories - Statement of Changes in Director/PDMR Shareholding <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

01/04/2016 15:52

RNS Number : 0745Q
Abbott Laboratories
24 February 2016
Notification to RNS
Company:  Abbott Laboratories
TIDM: ABT
Headline:  Abbott Laboratories Files Forms 4
Abbott Laboratories (the "Company")
24 February 2016
Abbott Laboratories Files Forms 4
The Company informs its shareholders that on 23 February 2016, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, several Forms 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") was filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 4 can be found on the SEC website at http://www.sec.gov.
Copies of the Forms 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial, Scott Leinenweber, +1-224-668-0791, or Media, Scott Stoffel, +1-224-668-5201.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSEAXALAFNKEFF